The US Deprescribing Research Network's 2025 Annual Meeting will be held in-person on May 7th in Chicago, on the pre-conference day of the American Geriatrics Society Annual Meeting! Join us to learn from leaders, network, & share ideas on improving medication use in older adults. Register & submit abstracts now! #Deprescribing #MedSafety #AgingResearch #Geriatrics https://lnkd.in/e4qQFEk
US Deprescribing Research Network (USDeN)
研究服务
San Francisco，CA 429 位关注者
Advancing research to optimize medication use among older adults.
关于我们
The goal of the US Deprescribing Research Network (USDeN) is to develop and disseminate evidence about deprescribing for older adults, and in doing so to help improve medication use among older adults and the outcomes that are important to them. Funded by the US National Institute on Aging, the network is a community of people united by a shared interest in improving research on deprescribing for older adults. The network’s key activities are designed to provide resources and supports that will catalyze expansion of the quality, quantity, and ultimate impact of deprescribing research, and to promote mutual learning and collaboration that is essential to this goal.
- 网站
-
https://deprescribingresearch.org/
US Deprescribing Research Network (USDeN)的外部链接
- 所属行业
- 研究服务
- 规模
- 2-10 人
- 总部
- San Francisco，CA
- 类型
- 非营利机构
- 创立
- 2019
地点
US Deprescribing Research Network (USDeN)员工
动态
-
#USDeNwebinar Please join us on 12/10 at 2pm ET/11am PT for: "Designing randomised controlled trials of deprescribing: learnings from the OPTiMISE trial" with Dr. James Sheppard Register here: https://lnkd.in/gxFKE_HK
-
US Deprescribing Research Network (USDeN)转发了
(fran?ais ci-dessous) The International Deprescribing Journal Club is back for its 10th edition on Dec. 12th 1PM - 2PM? ET! This next session, "Engaging inpatient clinicians in deprescribing: lessons from an implementation science approach", is hosted by the US Deprescribing Research Network (USDeN) and will welcome speaker Dr. Michelle S. Keller, PhD, MPH, assistant professor of Gerontology at the University Southern California. Dr. Keller will discuss the article "Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study”, with the objectives of:? 1. Describing how implementation science frameworks can be applied to design and evaluate deprescribing interventions. 2. Identifying effective strategies to engage inpatient clinicians in deprescribing practices, including overcoming barriers and leveraging facilitators for behavior change. Access article: https://lnkd.in/dhhGvkDu Register and find more info on the International Deprescribing Journal Club here: https://lnkd.in/d5UBtu4k Learn more about the US Deprescribing Research Network here: https://lnkd.in/eV-SG232 --- Le Club de lecture international sur la déprescription est de retour pour sa 10ème édition le 12 décembre de 13h à 14h (heure de l’est) ! Intitulée ? Engaging inpatient clinicians in deprescribing: lessons from an implementation science approach ?, cette prochaine session est organisée par le US Deprescribing Research Network et accueillera la Dre Michelle Keller, professeure adjointe en gérontologie à l’Université de la Californie du Sud. La Dre Keller présentera ses travaux sur l’identification de barrières et de facilitateurs à la déprescription de benzodiazépines et d’autres sédatifs-hypnotiques en contexte hospitalier, en utilisant le cadre des domaines théoriques et le modèle COM-B (capacité, opportunité, motivation comme facteurs de changement de comportement). La séance aura pour objectif de:? 1. Décrire comment des cadres issus de la science de la mise en ?uvre peuvent être appliqués à la conception et à l'évaluation des initiatives de déprescription. 2. Identifier des stratégies efficaces pour inciter les cliniciens en milieu hospitalier à adopter des pratiques de déprescription, notamment en surmontant les obstacles et en tirant parti des facilitateurs pour modifier les comportements. Accédez l'article : https://lnkd.in/dhhGvkDu * Veuillez noter que cet article ainsi que cette session sont disponibles en anglais seulement. Cliquez ici pour vous inscrire et pour plus d'infos sur le Club de lecture international sur la déprescription : https://lnkd.in/d5UBtu4k Pour en savoir plus sur le US Deprescribing Research Network (USDeN): https://lnkd.in/eV-SG232
-
-
US Deprescribing Research Network (USDeN)转发了
The?US Deprescribing Research Network?is pleased to announce?the?Request for Applications?for the?Grant Catalyst Scholars Program (GCSP) Program?is now?open!?The purpose of the Grant Catalyst Scholars Program is to accelerate research and career development for early-career investigators interested in deprescribing and related?fields, with a special focus on advancing their success in applying for and receiving grants?related to these areas. https://lnkd.in/gvS5VMNP
-
The US Deprescribing Research Network is pleased to announce a new Request for Application for Pilot Award! The maximum budget per award is $30,000 in direct costs (and no more than $50,000 in combined direct and indirect cost). Letter of Intent (Required): Due November 12, 2024 Full application: Due January 31, 2025 Read more about the RFA here: https://lnkd.in/e4gtpiX Informational Webinar: October 15, 2024 | 2PM ET / 11AM PT - Register Here: https://lnkd.in/guipM6Sk
-
The?US Deprescribing Research Network?is pleased to announce?the?Request for Applications?for the?Grant Catalyst Scholars Program (GCSP) Program?is now?open!?The purpose of the Grant Catalyst Scholars Program is to accelerate research and career development for early-career investigators interested in deprescribing and related?fields, with a special focus on advancing their success in applying for and receiving grants?related to these areas. https://lnkd.in/gvS5VMNP